3 New Strong Buy Ratings from Top-Rated Analysts: 05/02/2025
You want stock picks. We’ve got ‘em. Here’s your FREE preview of the latest upgrades from our Strong Buy Stocks from Top Wall Street Analysts screener:
- Pegasystems (NASDAQ: PEGA) just got a hefty price target increase from a top-rated analyst
- Liquidity Services (NASDAQ: LQDT) only has Buy ratings from the analysts we track
- Pediatrix Medical Group (NYSE: MD) enjoys strong implied upside from the smart money crowd
P.S. Just sayin’, you could get dozens of alerts like this per week … Try WallStreetZen Premium.
1. Pegasystems (NASDAQ: PEGA)
Pegasystems is in the business of enterprise software — helping other businesses automate workflows, improve customer engagement, and streamline their operations. The company recently delivered an exceptional double beat — and with solid growth prospects and an even stronger balance sheet, we think it’s worth a closer look.
Zen Rating: A (Strong Buy) — see full analysis >
Recent Price: $91.13 — get current quote >
Max 1-year forecast: $125.00
Why we’re watching:
- Pegasystems enjoys broad support from Wall Street analysts — with 5 Strong Buy ratings, 3 Buy ratings, and 2 Hold ratings. See the ratings
- Yun Kim of Loop Capital (a top 11% rated analyst) maintained a prior Strong Buy rating on PEGA shares on April 24, following the company’s Q1 2025 earnings. The analyst also raised their price target from $85 to $105.
- For Q1 2025, Pegasystems reported EPS of $1.53, which beat the Zacks Consensus Estimate of $0.46 and, by 218.8%, Q1 2024’s $0.48, and revenue of $475.63M, which beat the Zacks Consensus Estimate by 33.61% and, by 44%, Q1 2024’s $330.15M.
- The analyst said they anticipate that Pegasystems' consistent performance will continue, noting that management's commentary regarding the demand environment and its pipeline activity was optimistic.
- Pegasystems stock currently has a Zen Rating of A and ranks in the 96th percentile of equities tracked by our system.
- It’s hard to overstate how strong the company’s balance sheet is — but suffice to say, in terms of its Financials Component Grade rating, PEGA stock ranks in the top 1% (here’s why that matters). In addition, the company ranks highly in terms of Growth — in the 97th percentile, to be exact. (See all 7 Zen Component Grades here >)
2. Liquidity Services (NASDAQ: LQDT)
Liquidity Services operates online marketplaces — but they’re far from what you’d normally expect when you hear (or rather, read) that. The company’s platforms are geared toward corporations and government agencies and are designed to help them sell surplus assets, equipment, or inventory. LQDT has flown under the radar — and while few on Wall Street have recognized the stock’s potential, those that have are highly regarded.
Zen Rating: A (Strong Buy) — see full analysis >
Recent Price: $31.00 — get current quote >
Max 1-year forecast: $40.00
Why we’re watching:
- Only 2 analysts currently issue ratings for LQDT stock — and both have deemed it a Buy. See the ratings
- With that being said, we’re looking at another quality vs quantity situation here. The two researchers in question are Barrington Research’s Gary Prestopino (a top 12% rated analyst) and Craig-Hallum’s George Sutton (a top 12% rated analyst)
- Prestopino has a $40 price target for LQDT shares — while Sutton’s 12-month price forecast is $37.
- Liquidity Services stock has an overall Zen Rating of A, and ranks in the top 2% of stocks based on a holistic analysis of 115 proprietary factors that correlate with outsized returns.
- LQDT is currently the highest-rated stock in the entire Internet Retail industry.
- In addition, the company has beaten earnings estimates for 4 consecutive quarters, and will hold its next earnings call on May 8.
- Sentiment is LQDT’s strongest suit, as it ranks in the top 4% according to this category. However, Growth, where it ranks in the 95th percentile, is not far behind. (See all 7 Zen Component Grades here >)
3. Pediatrix Medical Group (NYSE: MD)
Our next entry is a healthcare provider that focuses on services geared toward newborns, children, and expectant mothers in the U.S. and Puerto Rico. While Pediatrix Medical Group hasn’t earned the full-fledged support of Wall Street (at least yet), our system has identified it as a strong performer in multiple key categories — and the busines looks set to continue a rather strong winning streak in place since early 2024.
Zen Rating: A (Strong Buy) — see full analysis >
Recent Price: $12.27 — get current quote >
Max 1-year forecast: $18.50
Why we’re watching:
- At present, 6 analysts issue ratings for MD stock, which has 1 Strong Buy rating, 1 Buy rating, and 4 Hold ratings. That might not sound promising at first — but keep reading, there’s more than meets the eye here. See the ratings
- For one, the average price target for Pediatrix shares currently stands at $16.75 — a figure that implies a hefty 36.73% upside from current prices.
- In addition, MD is currently the highest-rated stock in the entire Medical Care Facility industry.
- In 2024, the company delivered an EPS beat of at least 10% each quarter — so there’s a bit of a winning streak going on.
- Pediatrix shares currently rank in the 99th percentile of equities and carry an overall Zen Rating of A.
- In fact, the company’s Component Grade ratings are incredibly well-rounded. Pediatrix stock ranks in the top 5% according to Sentiment (here’s why Smart Money’s opinion matters), the top 8% in terms of Value, the top 10% in terms of Safety and Financials, and the top 11% in terms of Growth. (See all 7 Zen Component Grades here >)
What to Do Next?
Want to get in touch? Email us at news@wallstreetzen.com.
Keep Reading
See All News
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.